Literature DB >> 23875138

Improved visualization of the 70° arthroscope in the treatment of talar osteochondral defects.

Pietro Spennacchio1, Pietro Randelli, Paolo Arrigoni, Niek van Dijk.   

Abstract

Osteochondral defects (OCDs) of the talus are a common cause of residual pain after ankle injuries. When conservative treatment fails, arthroscopic debridement combined with drilling/microfracturing of the lesion (bone marrow stimulation [BMS] procedures) has been shown to provide good to excellent outcomes. Not uncommonly, talar OCDs involve the borders of the talar dome. These uncontained lesions are sometimes difficult to visualize with the 30° arthroscope, with potential negative effect on the clinical outcome of an arthroscopic BMS procedure. The use of the 70° arthroscope has been described for a multitude of common knee, shoulder, elbow, and hip procedures. The purpose of this article is to show the usefulness of the 70° arthroscope in arthroscopic BMS procedures, pointing out which kinds of talar OCDs can benefit most from its use.

Entities:  

Year:  2013        PMID: 23875138      PMCID: PMC3716212          DOI: 10.1016/j.eats.2013.01.001

Source DB:  PubMed          Journal:  Arthrosc Tech        ISSN: 2212-6287


  18 in total

1.  Use of the 70° arthroscope for improved visualization with common arthroscopic procedures.

Authors:  Asheesh Bedi; Joshua Dines; David M Dines; Bryan T Kelly; Stephen J O'Brien; David W Altchek; Answorth A Allen
Journal:  Arthroscopy       Date:  2010-09-19       Impact factor: 4.772

2.  Results of microfracture in the treatment of articular cartilage defects of the talus.

Authors:  Christoph Becher; Hajo Thermann
Journal:  Foot Ankle Int       Date:  2005-08       Impact factor: 2.827

3.  Advantages of 70° arthroscope in management of ECRB tendinopathy.

Authors:  P Arrigoni; L Zottarelli; P Spennacchio; M Denti; P Cabitza; P Randelli
Journal:  Musculoskelet Surg       Date:  2011-07

4.  Arthroscopic accessibility of the talus quantified by computed tomography simulation.

Authors:  Christiaan J A van Bergen; Gabriëlle J M Tuijthof; Mario Maas; Inger N Sierevelt; C Niek van Dijk
Journal:  Am J Sports Med       Date:  2012-08-08       Impact factor: 6.202

5.  Neurological complications of ankle arthroscopy.

Authors:  R D Ferkel; D D Heath; J F Guhl
Journal:  Arthroscopy       Date:  1996-04       Impact factor: 4.772

Review 6.  Outcome of arthroscopic debridement and microfracture as the primary treatment for osteochondral lesions of the talar dome.

Authors:  Michael P Donnenwerth; Thomas S Roukis
Journal:  Arthroscopy       Date:  2012-08-11       Impact factor: 4.772

7.  Osteochondral lesions of the talus: localization and morphologic data from 424 patients using a novel anatomical grid scheme.

Authors:  Ilan Elias; Adam C Zoga; William B Morrison; Marcus P Besser; Mark E Schweitzer; Steven M Raikin
Journal:  Foot Ankle Int       Date:  2007-02       Impact factor: 2.827

8.  Osteochondral lesions of the talus: predictors of clinical outcome.

Authors:  Daniel J Cuttica; W Bret Smith; Christopher F Hyer; Terrence M Philbin; Gregory C Berlet
Journal:  Foot Ankle Int       Date:  2011-11       Impact factor: 2.827

9.  Microfracture for osteochondral lesions of the ankle: outcome analysis and outcome predictors of 105 cases.

Authors:  Bavornrit Chuckpaiwong; Eric M Berkson; George H Theodore
Journal:  Arthroscopy       Date:  2007-11-19       Impact factor: 4.772

10.  Prognostic significance of the containment and location of osteochondral lesions of the talus: independent adverse outcomes associated with uncontained lesions of the talar shoulder.

Authors:  Woo Jin Choi; Gi Won Choi; Jun Shik Kim; Jin Woo Lee
Journal:  Am J Sports Med       Date:  2012-08-01       Impact factor: 6.202

View more
  1 in total

1.  A step-by-step arthroscopic examination of the anterior ankle compartment.

Authors:  J Vega; F Malagelada; J Karlsson; G M Kerkhoffs; M Guelfi; M Dalmau-Pastor
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-10-30       Impact factor: 4.342

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.